Business Context and Reporting Period
This Form 8-K filing by NanoViricides, Inc. (NNVC) reports a corporate governance event effective May 29, 2020. The company is incorporated in Nevada and its common stock trades on the NYSE-American.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the resignation of Mark Day from the following positions, effective May 29, 2020:
- Member of the Board of Directors
- Member of the Audit Committee
- Member of the Nominating and Compensation Committees
The company stated that Mr. Day's resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Key Facts for Investor Verification
- Verify the current composition of the Board of Directors following Mark Day's resignation.
- Confirm whether the Audit, Nominating, and Compensation Committees have been reconstituted to maintain quorum and compliance.
- Review subsequent filings for any impact on corporate governance or strategic direction.